Notably, a wide range of clinical phenotypes, ranging from ASD, cognitive impairment, and various types of epilepsy and seizures, have been related to de novo heterozygous missense or nonsense DNM1 pathogenic variants, probably resulting in a disrupted protein [18]. The gene discussed is DNM1; the disease is epilepsy.